Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Azitra Inc (AZTR)
NYSE MKT:AZTR
Holding AZTR?
Track your performance easily
AZTR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.43 - $68.40
Previous Close$0.47
Volume129.10K
Average Volume (3M)255.38K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$7.26M
Total Debt (Recent Filing)$643.35K
Price to Earnings (P/E)―
Beta2.28
Next Earnings
Mar 14, 2025EPS Estimate
-$0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.36
Shares Outstanding7,626,056
10 Day Avg. Volume207,471
30 Day Avg. Volume255,379
Standard Deviation0.29
R-Squared0.06
Alpha-0.19
Financial Highlights & Ratios
Price to Book (P/B)0.44
Price to Sales (P/S)473.22
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$3.00Price Target Upside535.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Azitra Inc News
PremiumPre-Earnings
Azitra Inc (AZTR) Q3 Earnings Cheat Sheet
Ownership Overview
15.29% Insiders
0.04% Mutual Funds
0.92% Other Institutional Investors
83.74% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
AZTR FAQ
What was Azitra Inc’s price range in the past 12 months?
Azitra Inc lowest stock price was $0.43 and its highest was $68.40 in the past 12 months.
What is Azitra Inc’s market cap?
Currently, no data Available
When is Azitra Inc’s upcoming earnings report date?
Azitra Inc’s upcoming earnings report date is Mar 14, 2025 which is in 110 days.
How were Azitra Inc’s earnings last quarter?
Azitra Inc released its earnings results on Nov 12, 2024. The company reported -$0.17 earnings per share for the quarter, beating the consensus estimate of -$0.415 by $0.245.
Is Azitra Inc overvalued?
According to Wall Street analysts Azitra Inc’s price is currently Undervalued.
Does Azitra Inc pay dividends?
Azitra Inc does not currently pay dividends.
What is Azitra Inc’s EPS estimate?
Azitra Inc’s EPS estimate is -$0.31.
How many shares outstanding does Azitra Inc have?
Azitra Inc has 7,626,056 shares outstanding.
What happened to Azitra Inc’s price movement after its last earnings report?
Azitra Inc reported an EPS of -$0.17 in its last earnings report, beating expectations of -$0.415. Following the earnings report the stock price went down -3.922%.
Which hedge fund is a major shareholder of Azitra Inc?
Currently, no hedge funds are holding shares in AZTR
---
Azitra Inc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (535.59% Upside)
$3.00 (535.59% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.2%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-98.81%
12-Months-Change
Fundamentals
Return on Equity
-134.85%
Trailing 12-Months
Asset Growth
30.54%
Trailing 12-Months
Company Description
Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library comprised of approximately 1,500 bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its product ATR-12 is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its product ATR-04 is a genetically modified strain of S. epidermidis for treating the papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease.
---
AZTR Stock 12 Month Forecast
Average Price Target
$3.00
▲(535.59% Upside)
Technical Analysis
Best Analysts Covering AZTR
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-55.86%
reiterated a buy rating 11 days ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -55.86% per trade.
---